About Spirig Pharma
Spirig Pharma is a Healthcare company based in Lausanne (Switzerland) founded in 1996, and was acquired by Stada in January 2012. Dermatology-focused biopharma products are developed by Spirig Pharma in Switzerland. Its focus areas include Life Sciences, Dermatology, Drugs and Aesthetics.
Company details
Spirig Pharma was founded in 1996 and based in Lausanne, Switzerland, as a biopharmaceutical company specializing in dermatology. Operations centered on treatments for conditions including acne, rosacea, psoriasis, and skin cancer precursors like actinic keratosis. Products were distributed in over 70 countries. The company was acquired by Galderma in 2012, integrating its portfolio into broader dermatological solutions.
Investors in Spirig Pharma
Spirig Pharma has secured backing from 1 investor. Prominent investors backing the company include Stada.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of generics and biosimilars | 1895 | stada.com | Bad Vilbel, Germany |
Investor details for Spirig Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Spirig Pharma
2 dated milestones of Spirig Pharma across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Spirig Pharma is founded.
- Exit Acquired by Stada.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spirig Pharma
Spirig Pharma was founded in 1996.
Spirig Pharma is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Spirig Pharma was founded in 1996 and based in Lausanne, Switzerland, as a biopharmaceutical company specializing in dermatology. Operations centered on treatments for conditions including acne, rosacea, psoriasis, and skin cancer precursors like actinic keratosis. Products were distributed in over 70 countries. The company was acquired by Galderma in 2012, integrating its portfolio into broader dermatological solutions.
Spirig Pharma has 1 investor. Key investors include Stada.
Yes. Spirig Pharma was acquired by Stada in January 2012.